Drug Discovery & Development Insights by OmicsX
No Result
View All Result
  • Login
  • Register
  • Home
  • Channels
  • Startups
  • Pipeline
  • Drug Targets
  • Bio Partnering
  • Opinion
PRICING
SUBSCRIBE
  • Home
  • Channels
  • Startups
  • Pipeline
  • Drug Targets
  • Bio Partnering
  • Opinion
No Result
View All Result
Drug Discovery & Development Insights by OmicsX
No Result
View All Result

Targeted Cancer Therapies – Antibodies

Insights on Monoclonal Antibodies, Bispecific Antibodies, Antibody Drug Conjugates and Fragment based Antibodies Approved & in Development.

2 years ago
in Antibodies, Oncology
Home Oncology Antibodies

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Articles in this Series –

  • Details on Approved Cancer Targeting Antibodies. (46 Molecules)
  • Monoclonal Antibodies in Active Clinical Development – Developers, Pipeline, Target & Cancer Indication. (112 Molecules)
  • Monoclonal Antibodies in Active Preclinical Development – Developers, Pipeline, Target & Cancer Indication. (200 Molecules)
  • Details on Approved Cancer Targeting BiSpecific Antibodies. (XX Molecules)
  • Bispecific Antibodies in Active Clinical Development – Developers, Pipeline, Targets & Cancer Indication. (XX Molecules)
  • Bispecific Antibodies in Active Preclinical Development – Developers, Pipeline, Targets & Cancer Indication. (XX Molecules)
  • Details on Approved Cancer Targeting Antibodies Drug Conjugates. (XX Molecules)
  • Antibody Drug Conjugates in Active Clinical Development – Developers, Pipeline, Targets & Cancer Indication. (XX Molecules)
  • Antibody Drug Conjugates in Active Preclinical Development – Developers, Pipeline, Targets & Cancer Indication. (XX Molecules)

Cancer Targeting Antibodies in Development

  • All
  • Monoclonal Antibodies
  • Bispecific Antibody
  • Antibody Drug Conjugate
Antibody Drug Conjugates
Antibody Drug Conjugate

Antibody Drug Conjugates

by Team OmicsX
June 18, 2022
0

Antibody Drug Conjugates (ADCs) are therapeutic entities with monoclonal antibody (mAb) backbone linked to cytotoxic drugs and are designed to improve/increase the therapeutic window of selected mAbs. ADCs now emerges as one of the hotspots for the research and development of anticancer drugs. Recent technology advances on new generation...

Read more
Bispecific Antibodies

Bispecific Antibodies

June 14, 2022
Clinical Stage Antibody Drug Conjugates in Active Development – 2021

Clinical Stage Antibody Drug Conjugates in Active Development – 2021

May 30, 2022

Pre-Clinical Stage Antibody Drug Conjugates in Active Development – 2021

May 30, 2022

Preclinical Stage Bispecific Antibodies in Active Development – 2021

May 30, 2022
Global Oncology Intelligence Global Oncology Intelligence Global Oncology Intelligence
Tags: Targeted Cancer Therapies
Share204Tweet127SendShare36
Previous Post

Small Molecule Epigenetic Drugs in Development – An Overview

Next Post

BiG Pharma – Oncology Insights & Updates

Next Post

BiG Pharma - Oncology Insights & Updates

Discussion about this post

Drug Discovery & Development Insights by OmicsX

Mapping Bio-Innovations

updated.. easy.. precise... complete...

Presenting filtered comprehensive information. Gain more insights on emerging bio-business, frame strategies, grow faster & better connect with biological science community.

LEARN MORE »

  • Trending
  • Comments
  • Latest
Approved Monoclonal Antibodies for Cancer Treatment

Approved Monoclonal Antibodies for Cancer Treatment

May 30, 2022
Approved Oncology Targeting Small Molecule Kinase Inhibitors

Approved Oncology Targeting Small Molecule Kinase Inhibitors

May 30, 2022

Kinase Inhibitors in Preclinical Development – 2021

May 30, 2022

Small Molecule Kinase Inhibitors – Preclinical Drug Developers

June 1, 2022

Small Molecule Kinase Inhibitors – Preclinical Drug Developers

0
Hoffmann-La Roche – Oncology Drug Pipeline Insights – June 2021

Hoffmann-La Roche –
Oncology Drug Pipeline Insights – June 2021

0
AbbVie, Inc. – Oncology Drug Pipeline Insights – June 2021

AbbVie, Inc. –
Oncology Drug Pipeline Insights – June 2021

0
Amgen, Inc.  Oncology Drug Pipeline Analysis – June 2021

Amgen, Inc.
Oncology Drug Pipeline Analysis – June 2021

0
Emerging Drug Developers Developing Cancer Targeting Exosomes

Emerging Drug Developers Developing Cancer Targeting Exosomes

July 10, 2022
Cancer Microbiome Targeting Emerging Drug Developers

Cancer Microbiome Targeting Emerging Drug Developers

July 9, 2022
Antibody Drug Conjugates

Antibody Drug Conjugates

June 18, 2022
Oncolytic Viruses

Oncolytic Viruses

June 29, 2022

Developed by OmicsX. The entirety of this site is protected by copyright © 2010–2021 HH BioTechnologies Private Ltd.

No Result
View All Result
  • Home
  • Subscription
  • Category
    • Opinion
    • Tech
  • Landing Page
  • Buy JNews
  • Support Forum
  • Pre-sale Question
  • Contact Us

Developed by OmicsX. The entirety of this site is protected by copyright © 2010–2021 HH BioTechnologies Private Ltd.

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

*By registering into our website, you agree to the Terms & Conditions and Privacy Policy.
All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?